Ärzteblatt Sachsen 11|2021
Literatur
[1] Schneider A, Großmann N, Linde K. The development of general practice as an academic discipline in Germany - an analysis of research output between 2000 and 2010. BMC Fam Pract 2012;13(1):58. doi:10.1186/1471-2296-13-58 [published Online First: 15 June 2012].
[2] Hummers-Pradier E, Bleidorn J, Schmiemann G, et al. General practice-based clinical trials in Germany – a problem analysis. Trials 2012;13:205.
[3] Brænd AM, Jensen KB, Klovning A, et al. Clinical drug trials in general practice: a 10-year overview of protocols.
Trials 2013;14(1):162. doi:10.1186/1745-6215-14-162 [published Online First: 1 June 2013].
[4] Gágyor I, Bleidorn J, Wegscheider K, et al. Practices, patients and (im)perfect data--feasibility of a randomised controlled clinical drug trial in German general practices. Trials 2011;12(1):91. doi:10.1186/1745-6215-12-91 [published Online First: 1 April 2011].
[5] Fortin M, Stewart M, Poitras M-E, et al. A systematic review of prevalence studies on multimorbidity: toward a more uniform methodology. The Annals of Family Medicine 2012;10(2):142–51.
[6] Ornstein SM, Nietert PJ, Jenkins RG, et al. The prevalence of chronic diseases and multimorbidity in primary care practice: a PPRNet report. The Journal of the American Board of Family Medicine 2013;26(5):518–24.
